Renata enters Dutch market with Parkinson's disease drug
Bangladesh, Nov. 18 -- Renata has expanded its footprint in the European market by launching a Parkinson's disease medicine in the Netherlands.
Advertisement
The drug maker has launched Amantadine HCl 100 mg hard capsules in the Dutch market, targeting patients receiving symptomatic treatment for Parkinson's disease, according to a stock exchange disclosure on Tuesday.
The move comes as the company seeks to strengthen its global competitiveness, diversify export destinations and capture a larger share of the international medicine market.
The launch in the Netherlands is part of a broader strategy to diversify the company's overseas business, expand its geographical reach and build a stronger commercial presence in Europe, according t...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.